Disposition of 4747 shares by Barnett Eva Renee of Immunovant at 28.06 subject to Rule 16b-3
| LYFCX Fund | USD 12.99 0.15 1.17% |
Slightly above 50% of Alphacentric Lifesci's investors are presently thinking to get in. The analysis of overall sentiment of trading Alphacentric Lifesci Healthcare mutual fund suggests that some investors are interested at this time. Alphacentric Lifesci's investing sentiment can be driven by a variety of factors including economic data, Alphacentric Lifesci's earnings reports, geopolitical events, and overall market trends.
Alphacentric |
Filed transaction by Immunovant Officer Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Alphacentric Lifesci Fundamental Analysis
We analyze Alphacentric Lifesci's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alphacentric Lifesci using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alphacentric Lifesci based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Equity Positions Weight
Equity Positions Weight Comparative Analysis
Alphacentric Lifesci is currently under evaluation in equity positions weight among similar funds. Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
Alphacentric Lifesci Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alphacentric Lifesci mutual fund to make a market-neutral strategy. Peer analysis of Alphacentric Lifesci could also be used in its relative valuation, which is a method of valuing Alphacentric Lifesci by comparing valuation metrics with similar companies.
Peers
Alphacentric Lifesci Related Equities
| PLMPX | Pimco Emerging | 0.28 | ||||
| IGIEX | Ashmore Emerging | 0.12 | ||||
| BXECX | Barings Emerging | 0.13 | ||||
| PIEFX | Pnc Emerging | 1.32 | ||||
| REMVX | Rbc Emerging | 1.56 | ||||
| EGLNX | Eagle Mlp | 1.61 | ||||
| GAGPX | Goldman Sachs | 1.80 | ||||
| JFAMX | Jpmorgan Emerging | 2.09 |
Other Information on Investing in Alphacentric Mutual Fund
Alphacentric Lifesci financial ratios help investors to determine whether Alphacentric Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alphacentric with respect to the benefits of owning Alphacentric Lifesci security.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |